Literature DB >> 25652002

Comparing interventions and exploring neural mechanisms of exercise in Parkinson disease: a study protocol for a randomized controlled trial.

Gammon M Earhart1,2,3, Ryan P Duncan4,5, John L Huang6, Joel S Perlmutter7,8,9, Kristen A Pickett10.   

Abstract

BACKGROUND: Effective treatment of locomotor dysfunction in Parkinson disease (PD) is essential, as gait difficulty is an early and major contributor to disability. Exercise is recommended as an adjunct to traditional treatments for improving gait, balance, and quality of life. Among the exercise approaches known to improve walking, tango and treadmill training have recently emerged as two promising therapies for improving gait, disease severity and quality of life, yet these two interventions have not been directly compared to each other. Prior studies have been helpful in identifying interventions effective in improving gait function, but have done little to elucidate the neural mechanisms underlying functional improvements. The primary objective of the proposed work is to compare the effects of three community-based exercise programs, tango, treadmill training and stretching, on locomotor function in individuals with PD. In addition, we aim to determine whether and how these interventions alter functional connectivity of locomotor control networks in the brain. METHODS/
DESIGN: One hundred and twenty right-handed individuals with idiopathic PD who are at least 30 years of age will be assigned in successive waves to one of three community-based exercise groups: tango dancing, treadmill training or stretching (control). Each group will receive three months of exercise training with twice weekly one-hour group classes. Each participant will be evaluated at three time points: pre-intervention (baseline), post-intervention (3 months), and follow-up (6 months). All evaluations will include assessment of gait, balance, disease severity, and quality of life. Baseline and post-intervention evaluations will also include task-based functional magnetic resonance imaging (fMRI) and resting state functional connectivity MRI. All MRI and behavioral measures will be conducted with participants OFF anti-Parkinson medication, with behavioral measures also assessed ON medication. DISCUSSION: This study will provide important insights regarding the effects of different modes of exercise on locomotor function in PD. The protocol is innovative because it: 1) uses group exercise approaches for all conditions including treadmill training, 2) directly compares tango to treadmill training and stretching, 3) tests participants OFF medication, and 4) utilizes two distinct neuroimaging approaches to explore mechanisms of the effects of exercise on the brain. TRIAL REGISTRATION: ClinicalTrials.gov NCT01768832 .

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25652002      PMCID: PMC4326476          DOI: 10.1186/s12883-015-0261-0

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  38 in total

1.  Evaluation of a screening questionnaire for genetic studies of Parkinson's disease.

Authors:  B A Racette; M Rundle; A Parsian; J S Perlmutter
Journal:  Am J Med Genet       Date:  1999-10-15

Review 2.  The nature of Parkinson's disease.

Authors:  D B Calne
Journal:  Neurochem Int       Date:  1992-03       Impact factor: 3.921

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Long-term effect of body weight-supported treadmill training in Parkinson's disease: a randomized controlled trial.

Authors:  Ichiro Miyai; Yasuyuki Fujimoto; Hiroshi Yamamoto; Yoshishige Ueda; Toshio Saito; Sonoko Nozaki; Jin Kang
Journal:  Arch Phys Med Rehabil       Date:  2002-10       Impact factor: 3.966

Review 5.  The biomechanics and motor control of gait in Parkinson disease.

Authors:  M E Morris; F Huxham; J McGinley; K Dodd; R Iansek
Journal:  Clin Biomech (Bristol, Avon)       Date:  2001-07       Impact factor: 2.063

6.  The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score.

Authors:  C Jenkinson; R Fitzpatrick; V Peto; R Greenhall; N Hyman
Journal:  Age Ageing       Date:  1997-09       Impact factor: 10.668

7.  What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.

Authors:  A J Hughes; Y Ben-Shlomo; S E Daniel; A J Lees
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910

8.  Brain activations during motor imagery of locomotor-related tasks: a PET study.

Authors:  Francine Malouin; Carol L Richards; Philip L Jackson; Francine Dumas; Julien Doyon
Journal:  Hum Brain Mapp       Date:  2003-05       Impact factor: 5.038

Review 9.  The role of gait rhythmicity and bilateral coordination of stepping in the pathophysiology of freezing of gait in Parkinson's disease.

Authors:  Meir Plotnik; Jeffrey M Hausdorff
Journal:  Mov Disord       Date:  2008       Impact factor: 10.338

10.  The evolution of disability in Parkinson disease.

Authors:  Lisa M Shulman; Ann L Gruber-Baldini; Karen E Anderson; Christopher G Vaughan; Stephen G Reich; Paul S Fishman; William J Weiner
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

View more
  15 in total

1.  Cerebellar Volume and Executive Function in Parkinson Disease with and without Freezing of Gait.

Authors:  Peter S Myers; Marie E McNeely; Jonathan M Koller; Gammon M Earhart; Meghan C Campbell
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

2.  Maximum Step Length Test Performance in People With Parkinson Disease: A Cross-sectional Study.

Authors:  Ryan P Duncan; Marie E McNeely; Gammon M Earhart
Journal:  J Neurol Phys Ther       Date:  2017-10       Impact factor: 3.649

3.  Investigation of factors impacting mobility and gait in Parkinson disease.

Authors:  Gustavo Christofoletti; Marie E McNeely; Meghan C Campbell; Ryan P Duncan; Gammon M Earhart
Journal:  Hum Mov Sci       Date:  2016-08-20       Impact factor: 2.161

4.  A pilot study to evaluate multi-dimensional effects of dance for people with Parkinson's disease.

Authors:  Maria I Ventura; Deborah E Barnes; Jessica M Ross; Kimberly E Lanni; Karen A Sigvardt; Elizabeth A Disbrow
Journal:  Contemp Clin Trials       Date:  2016-10-17       Impact factor: 2.226

5.  Low to moderate relationships between gait and postural responses in Parkinson disease.

Authors:  Ellen N Sutter; Katie J Seidler; Ryan P Duncan; Gammon M Earhart; Marie E McNeely
Journal:  J Rehabil Med       Date:  2017-06-28       Impact factor: 2.912

6.  The feasibility of singing to improve gait in Parkinson disease.

Authors:  Elinor C Harrison; Marie E McNeely; Gammon M Earhart
Journal:  Gait Posture       Date:  2017-02-14       Impact factor: 2.840

7.  Establishing Equivalent Aerobic Exercise Parameters Between Early-Stage Parkinson's Disease and Pink1 Knockout Rats.

Authors:  Michael F Salvatore; Isabel Soto; Ella A Kasanga; Rachael James; Marla K Shifflet; Kirby Doshier; Joel T Little; Joshia John; Helene M Alphonso; J Thomas Cunningham; Vicki A Nejtek
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

8.  Effects of exercise on gait and motor imagery in people with Parkinson disease and freezing of gait.

Authors:  Peter S Myers; Marie E McNeely; Kristen A Pickett; Ryan P Duncan; Gammon M Earhart
Journal:  Parkinsonism Relat Disord       Date:  2018-05-08       Impact factor: 4.891

Review 9.  Long-term effects of exercise and physical therapy in people with Parkinson disease.

Authors:  Margaret K Mak; Irene S Wong-Yu; Xia Shen; Chloe L Chung
Journal:  Nat Rev Neurol       Date:  2017-10-13       Impact factor: 42.937

10.  Resting-state functional connectivity associated with gait characteristics in people with Parkinson's disease.

Authors:  Adam P Horin; Peter S Myers; Kristen A Pickett; Gammon M Earhart; Meghan C Campbell
Journal:  Behav Brain Res       Date:  2021-06-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.